Tanthius2014-03-13 05:52
LIST2,$MeetMe(MEET)$ ,$阿库拉制药(ACUR)$ ,$Accretive Health (AH)$ ,$IMRIS INC(IMRS)$ ,$ZIOPHARM Oncology(ZIOP)$ ,$Merrimack(MACK)$ ,$RIT科技(RITT)$查看全文
$阿库拉制药(ACUR)$ 内部交易: 2017-12-14,高级VP and CFO,CLEMENS PETER A ,买入,300000普通股, $0.10
$阿库拉制药(ACUR)$ 内部交易: 2017-12-14,VP, Controller & Treasurer,Seiser Robert A ,买入,300000普通股, $0.10
$阿库拉制药(ACUR)$ 内部交易: 2017-12-14,Director,WESSON BRUCE F ,买入,335734普通股, $0.10
$阿库拉制药(ACUR)$ 内部交易: 2017-12-14,VP Technical Affairs - APT,Brzeczko Albert W ,买入,300000普通股, $0.10
$阿库拉制药(ACUR)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2017-11-17 AccNo: 0001144204-17-059941 Size: 152 KB 网页链接
$阿库拉制药(ACUR)$ 8-K - Current report Filed: 2017-11-14 AccNo: 0001144204-17-058998 Size: 88 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial St...
$阿库拉制药(ACUR)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-11-13 AccNo: 0001144204-17-058390 Size: 4 MB 网页链接
$阿库拉制药(ACUR)$ 8-K - Current report Filed: 2017-11-13 AccNo: 0001144204-17-058378 Size: 118 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$阿库拉制药(ACUR)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-11-13 AccNo: 0001144204-17-058390 Size: 4 MB 网页链接
$阿库拉制药(ACUR)$ 8-K - Current report Filed: 2017-11-13 AccNo: 0001144204-17-058378 Size: 118 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接